Guangdong Biolight Meditech Co., Ltd. (SHE:300246)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
industry		735.36M	776.52M	765.93M	705.96M	1.10B
industry Growth		-5.30%	1.38%	8.49%	-35.75%	107.21%
Business		312.44M	401.30M	397.79M	368.31M	286.88M
Business Growth		-22.14%	0.88%	8.00%	28.39%	0.08%
Unallocated Other Operating Income		12.68M	16.18M	19.98M	16.74M	10.39M
Unallocated Other Operating Income Growth		-21.64%	-19.00%	19.31%	61.19%	14.69%
Total		1.06B	1.19B	1.18B	1.09B	1.40B
Total Growth		-11.18%	0.87%	8.49%	-21.85%	69.02%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
China		799.75M	929.82M	877.52M	750.99M	679.01M
China Growth		-13.99%	5.96%	16.85%	10.60%	2.66%
Export		248.06M	248.00M	286.20M	323.29M	706.62M
Export Growth		0.02%	-13.35%	-11.47%	-54.25%	354.36%
Unallocated		12.68M	16.18M	19.98M	16.74M	10.39M
Unallocated Growth		-21.64%	-19.00%	19.31%	61.19%	14.69%
Total		1.06B	1.19B	1.18B	1.09B	1.40B
Total Growth		-11.18%	0.87%	8.49%	-21.85%	69.02%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 22, 2026

Data Sources Report a data error